Journal profile · Clinical Neurology
Parkinsonism & Related Disorders
ISSN 1353-8020 · eISSN 1873-5126 · Elsevier BV · ENGLAND · Quarterly · Founded 1995
Parkinsonism & Related Disorders: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.26; hybrid open access; APC about USD 3,460; median 81 days to acceptance (111 articles, last 24 months); community-reported acceptance: fairly easy (Elsevier website: 29%); 808 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Parkinsonism & Related Disorders is published by Elsevier BV and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Genetic Neurodegenerative Diseases, together about 56% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Parkinsonism & Related Disorders publishes the results of translational and clinical research contributing to the understanding, diagnosis and treatment of movement disorders and all neurodegenerative syndromes in which parkinsonism, essential tremor or related movement disorders may be a feature. Parkinsonism & Related Disorders welcomes reviews, points of views, original articles, short communications, interesting cases for movement disorder rounds and correspondences to the editor.Topics covered include: Molecular biologyNeuroanatomyNeurophysiology/electrophysiology Neuropharmacology Neuropsychology Neuroimaging Neurotoxicology Clinical phenomenology Surgical and pharmacological treatment Transplantation studies Relationship with aging Epidemiology/environmental impact factors RehabilitationThe journal aims to form a truly international channel of communication between the research and clinical communities.Parkinsonism & Related Disorders is a companion journal to Clinical Parkinsonism & Related Disorders. Manuscripts with a primary focus on clinical aspects of movement disorders should be submitted to Clinical Parkinsonism & Related Disorders.Clinical Parkinsonism & Related Disorders is affiliated with the International Association of Parkinsonism and Related Disorders.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief H. FernandezPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 26, Italy 8, Germany 6, Malaysia 4, South Korea 3 (79 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Parkinson's Disease Mechanisms and TreatmentsMedicine29.5%
- Neurological disorders and treatmentsMedicine20%
- Genetic Neurodegenerative DiseasesNeuroscience6.5%
- Botulinum Toxin and Related Neurological DisordersMedicine4.9%
- Parkinson's Disease and Spinal DisordersMedicine4.2%
- Balance, Gait, and Falls PreventionHealth Professions3.3%
- Neurological diseases and metabolismNeuroscience2.9%
- Transcranial Magnetic Stimulation StudiesNeuroscience2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.26LetPub ·
- Impact factor (publisher)
- 4.3Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- CiteScore (publisher)
- 5.9Publisher website ·
- SJR 2026-06
- 1.24LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 84LetPub ·
- h-index
- 157OpenAlex ·
- i10-index
- 4,225OpenAlex ·
- 2-year mean citedness
- 1.71OpenAlex ·
- Self-citation rate
- 4.7%LetPub ·
- Share of gold OA articles
- 21.57%LetPub ·
Volume
- Articles per year
- 254LetPub ·
Articles by year OpenAlex count · 12,684 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 310 | 107 | 69 |
| 2025 | 808 | 163 | 882 |
| 2024 | 795 | 173 | 2,318 |
| 2023 | 582 | 143 | 3,055 |
| 2022 | 310 | 144 | 3,620 |
| 2021 | 367 | 151 | 5,845 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
81 daysMedian, submission to acceptance · P25–P75 62 days – 105 days
- Acceptance to online
- median 2 days (111 articles)
- Submission to online
- median 84 days
- Sample
- 111 articles with submission and acceptance dates (795 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- 29%LetPub ·
- Submission to first decision
- 10 daysPublisher website ·
- First decision after review
- 44 daysPublisher website ·
- Submission to acceptance
- 75 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,460 / EUR 3,240 / GBP 2,770 / JPY 429,140 | — | — | |
| Publisher website | USD 3,670 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted10
- case reportReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- correspondenceReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- full-length articlesFull-length Articles reporting original results of research within the field of Parkinsonism & Related Disorders. The maximum length allowed will be 4000 words,…Length not stated
- hypothesisReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- movement disorder roundsMovement disorder rounds is a new section in Parkinsonism & Related Disorders featuring two parts in a full manuscript. For the first part, submission will come…Length not stated
- point of viewPoint of View Articles on challenged conventional ideas or hypotheses and which could invite further discussion or debate through correspondence or articles in …Length not stated
- reviewReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- review articleReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- short communicationReview Articles of specialized topics within the scope of the journal. The maximum length allowed will be 4000 words, not including the abstract (max. 250 words…Length not stated
- short communicationsShort Communications reporting on research that has progressed to the stage where preliminary publication is appropriate. The maximum length allowed will be 200…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access options available Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier BV
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1995
- ISSN
- 1353-8020
- Electronic ISSN
- 1873-5126
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Parkinsonism & Related Disorders
What CAS zone is Parkinsonism & Related Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Parkinsonism & Related Disorders is in Zone 3 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Parkinsonism & Related Disorders?
The latest impact factor listed by LetPub is 4.26; CiteScore 5.9, h-index 157.
How long does peer review take at Parkinsonism & Related Disorders?
Based on the dates recorded on 111 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 62–105 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy (Elsevier website: 29%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Parkinsonism & Related Disorders?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,000 words; Reference style: Numbered, in order of citation; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Parkinsonism & Related Disorders based?
Of the 79 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (26), Italy (8) and Germany (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Parkinsonism & Related Disorders?
According to LetPub and DOAJ records, Parkinsonism & Related Disorders is indexed in SCIE and Scopus.
Is Parkinsonism & Related Disorders open access, and what is the APC?
Parkinsonism & Related Disorders is a hybrid journal. For open-access publication: APC about USD 3,460.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .